BBSN.L

Brave Bison Group Plc
Brave Bison Grp PLC - Reduction of Capital Effective
21st October 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8087I
Brave Bison Group PLC
21 October 2024
 

21 October 2024

 

 

Brave Bison Group plc

("Brave Bison" or the "Company")

 

Reduction of Capital Effective

 

Brave Bison, the digital advertising and technology services company, announces that the Reduction of Capital approved by Brave Bison shareholders in June 2024 has now become effective.

 

The increase in distributable reserves created by the Reduction of Capital supports both the potential future payment by the Company of dividends to Shareholders as well as future share buybacks should circumstances dictate that it is desirable to do so.

 

Whilst there is no current intention to return any amounts to shareholders the Board intends to keep this under review and wishes to be able to proceed if this is thought to be in Shareholders' interests.

 

At the annual general meeting of the Company held on 19 June 2024 (the "AGM"), all resolutions proposed to the shareholders of the Company (the "Shareholders"), as set out in the notice of AGM sent to Shareholders on 24 May 2024 (the "Notice of AGM"), were passed by the Shareholders.

 

The resolutions passed at the AGM included those in respect of the Reduction of Capital, whereby the Company proposed to cancel (i) all of the B Ordinary Shares, (ii) the share premium account, and (iii) the capital redemption reserve.

 

In connection with the Reduction of Capital, and in accordance with the resolutions passed at the AGM, on 7 October 2024, the Company capitalised £62,624,450 (being the amount standing to the credit of the Company's merger relief reserve) and allotted and issued 1,291,813,947 B Ordinary Shares.

 

The Reduction of Capital required Court approval and the Company is pleased to announce that Court approval has now been obtained. Following registration of the Court order approving the Reduction of Capital with Companies House on 17 October 2024, the Reduction of Capital is now effective, and as a result, has increased the Company's distributable reserves by £158,436,206.60.

 

Following the implementation of the Reduction of Capital there is no change to the number of Ordinary Shares in issue (or their nominal value), and no new share certificates will be issued as a result of the Reduction of Capital.

 

Capitalised terms used in this announcement, and not otherwise defined, have the same meaning as given in the Notice of AGM.

 

For further information please contact:

 

Brave Bison Group plc

via Cavendish

Oliver Green, Executive Chairman


    Theo Green, Chief Growth Officer


    Philippa Norridge, Chief Financial Officer




Cavendish Capital Markets

+44 (0) 20 7220 0500

Nominated Adviser & Broker


Ben Jeynes


Dan Hodkinson




-ENDS-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CARMPBBTMTBBBII]]>
TwitterFacebookLinkedIn